Kimberly-Clark Buys Tylenol at $48B
On 3 November 2025, Kimberly-Clark announced that it would acquire Kenvue, the consumer-health company behind Tylenol and other over-the-counter brands, in a cash-and-stock deal valued at approximately US$48.7 billion. Under the terms of the transaction, Kimberly-Clark shareholders would own about 54 % of the combined entity, while Kenvue shareholders would hold about 46 %.The merged […]
